Web seminar recordings
QIAGEN Clinical Insight (QCI) Interpret identifies targeted therapy and clinical trials in hematological tumors
2,221 views
Hematological malignancies originating from hematopoietic and lymphoid tissue are complex heterogeneous diseases characterized by distinct clinicopathological features and molecular alterations. The heterogeneity of leukemia and lymphoma has presented massive challenges for identifying the appropriate treatment for each patient. Advances in next-generation sequencing (NGS) have presented unique treatment opportunities beyond standard of care and chemotherapy. QIAGEN® Clinical Insight (QCI™ Interpret) is a web-based application for the annotation, classification, and reporting of clinically actionable variants from NGS data in clinical genomics laboratories.
Interested in learning more?
Click here
Related videos
Web seminar recordings
Translational research: Find the needle in the haystack and access trustworthy knowledge of known...
Get connected to the industry’s most comprehensive collection of biological...
Web seminar recordings
More effective and efficient routine testing for somatic analysis and interpretation – a live...
See why laboratories across the globe choose QIAGEN solutions for routine...
Web seminar recordings
Clinical Metagenomics for Rapid Detection of Enteric Pathogens and Characterization of the...
High-throughput sequencing, combined with high-resolution metagenomic...
Web seminar recordings
Part 2: Use of QCI Interpret to elucidate precision in breast cancer targeted therapy
Interested in learning more? Click here